Ignite Creation Date:
2024-07-17 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06490653
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-06-29
Brief Title:
Tranexamic Acid Versus Blood Stopper Treatments in Epistaxis Management
Sponsor:
Ankara Ataturk Sanatorium Training and Research Hospital
Organization:
Ankara Ataturk Sanatorium Training and Research Hospital
Study Overview
Official Title:
Comparison of the Efficacy of Tranexamic Acid and Blood Stopper Treatments in Bleeding Control in Patients With Epistaxis A Randomized Controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this randonmized controlled trial aim to compare the effectiveness of local administration of tranexamic acid and blood stopper Ankaferd on cessation of bleeding in epistaxis patients
Detailed Description:
Anterior tamponade is frequently used in the management of anterior epistaxis However this procedure is often uncomfortable for patients Therefore instead of this physical tampon various pharmacologic agents such as tranexamic acid blood stoppers ankaferd and adrenaline can be used in epistaxis management Although the superiority of various agents used in the management of anterior epistaxis has been evaluated in published network meta-analyses these meta-analyses do not compare ankaferd and Tranexamic acid since there are no studies with each other In order to close the gap in the existing literature this study aims to evaluate the superiority of local administration of tranexamic acid and ankaferd in terms of cessation of bleeding in patients with anterior epistaxis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None